These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6564828)

  • 1. In-vitro activity of augmentin against clinically important gram-positive and gram-negative bacteria in comparison with other antibiotics.
    Focht J; Klietmann W; Heilmann HD
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Apr; 256(4):523-30. PubMed ID: 6564828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of augmentin as a beta-lactam antibiotic in surgical and medical practice.
    Kirei BR; Mhalu FS; Pallangyo PK; Seif SA
    East Afr Med J; 1987 Jul; 64(7):499-503. PubMed ID: 3691365
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous Augmentin in bacteraemia and severe invasive polymicrobial sepsis.
    Mehtar S; Ball AP
    J Antimicrob Chemother; 1985 Jun; 15(6):765-71. PubMed ID: 4030538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An initial assessment of augmentin for the treatment of paediatric infections in general practice.
    Jeffries MG; Rose AJ; Williams HN
    Br J Clin Pract; 1983 Feb; 37(2):61-6. PubMed ID: 6860540
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
    Tan TH; Tay L; Yeo M; Feng PH
    Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.
    Glupczynski Y; McGillavry G; Yourassowsky E
    Acta Clin Belg; 1988; 43(2):109-14. PubMed ID: 3400375
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor.
    Parish LC; Aten EM
    Cutis; 1984 Dec; 34(6):567-70. PubMed ID: 6394217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug therapy: Augmentin.
    Klaus JR; Ross MF; Knodel LC
    J Pediatr Health Care; 1988; 2(2):113-5. PubMed ID: 3258378
    [No Abstract]   [Full Text] [Related]  

  • 9. Amoxicillin-clavulanic acid (Augmentin).
    Med Lett Drugs Ther; 1984 Nov; 26(674):99-100. PubMed ID: 6387417
    [No Abstract]   [Full Text] [Related]  

  • 10. Chromosomally mediated intrinsic resistance to penicillin of penicillinase producing strains of Neisseria gonorrhoeae isolated in Sydney: guide to treatment with Augmentin.
    Tapsall JW; Phillips EA; Morris LM
    Genitourin Med; 1987 Oct; 63(5):305-8. PubMed ID: 3119461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical and bacteriological evaluation of Augmentin: a new broad spectrum antibiotic in general practice.
    Hansrod D; Howalder R; Rozar GJ
    East Afr Med J; 1983 Nov; 60(11):778-82. PubMed ID: 6368188
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentin therapy in the treatment of urinary tract infections in general practice.
    Abbas AM; Goel PK; Venkit N; Gowers E
    Br J Clin Pract; 1984 Feb; 38(2):49-51. PubMed ID: 6704296
    [No Abstract]   [Full Text] [Related]  

  • 13. [The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].
    Zubkov MN; Nonikov VE; Gugutsidze EN; Sutormina TM; Makarova OV
    Antibiot Khimioter; 1992 Sep; 37(9):34-6. PubMed ID: 1444669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 15. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
    Parker RH; Eggleston M
    Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of augmentin against pathogenic bacteria and its comparison with other antibiotics.
    Perryman F; Johnson S; Qadri SM
    Chemotherapy; 1983; 29(2):111-5. PubMed ID: 6839863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
    Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.
    Focht J; Klietmann W; Nösner K; Rolinson GN; Johnsen J
    Chemotherapy; 1988; 34(4):332-40. PubMed ID: 3264780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of the amoxicillin-clavulanic acid (augmentin) combination on strains of hospital isolates].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1985 May; 33(5):301-8. PubMed ID: 3929215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.